Reuters reports that Thailand is to begin making its own generic version of the AIDs drug Efavirenz under a compulsory licence from June 2007. This has angered the patent-owner, Merck, which has said that it has not been consulted. The company will receive a 0.5% royalty on all sales, which will be made at approximately half the usual selling price. Thailand currently have 580,000 people suffering from HIV/AIDs.
The IPKat says that this could prove an important test for the meaning of the TRIPs national emergencies exception.
THAI AIDS COMPULSORY LICENCE Reviewed by Unknown on Friday, December 01, 2006 Rating: